Amgen will present the results from four Phase 2 studies of AMG 145 at the American Heart Association (AHA) Scientific Sessions 2012, taking place in Los Angeles November 3-7, 2012.

Abstracts are available online here.

If you are at AHA, stop by Amgen's booth #646 to learn more.

Follow Amgen on Twitter at http://twitter.com/amgen to receive news updates during AHA.